David L. Wiest

Fox Chase Cancer Center

NIH Rank #6200
  • Program Leader
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.8M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#6,200
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.8M across 4 grants · National rank #6200.

Top grants by award amount

David L. Wiest's NIH grant portfolio, ranked by award amount.

  • 5R01CA283396-02R01
    Divergent Functions of ERK Substrate Binding Domains in Pathogenesis of Myeloproliferative Neoplasms
    $671.7K
    award amount
  • 5R37AI110985-10R37
    Regulation of hematopoiesis by ribosomal protein paralogs
    $561K
    award amount
  • 5P01AI138962-05P01
    Inherited T cell defects: Diagnosis, Mechanisms and Treatments
    $517.7K
    award amount
  • 1R03CA286669-01R03
    Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer
    $94K
    award amount

Affiliations

Institutions that have administered grants for David L. Wiest.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Fox Chase Cancer Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6200
  5. 2024
    Multi-Institutional Research
    Awards at 2 institutions